Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides

Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides

Fighting COVID-19 with high affinity reagents: this review article summarizes the discovery of several classes of (bio) molecules targeting the SARS-CoV-2 spike protein.

Bibliographic Details
Main Author:	Pomplun, Sebastian Johannes (Author)
Other Authors:	Massachusetts Institute of Technology. Department of Chemistry (Contributor)
Format:	Article
Language:	English
Published:	Royal Society of Chemistry (RSC), 2021-06-02T20:07:16Z.
Subjects:	Article
Online Access:	Get fulltext


LEADER	00701 am a22001453u 4500
001	130898
042			\|a dc
100	1	0	\|a Pomplun, Sebastian Johannes \|e author
100	1	0	\|a Massachusetts Institute of Technology. Department of Chemistry \|e contributor
245	0	0	\|a Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides
260			\|b Royal Society of Chemistry (RSC), \|c 2021-06-02T20:07:16Z.
856			\|z Get fulltext \|u https://hdl.handle.net/1721.1/130898
520			\|a Fighting COVID-19 with high affinity reagents: this review article summarizes the discovery of several classes of (bio) molecules targeting the SARS-CoV-2 spike protein.
655	7		\|a Article
773			\|t RSC Medicinal Chemistry